<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">469074345</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323132931.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170328e19920701xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF01741791</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF01741791</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Joep Bergers, Willem Den Otter, Jan De Groot, Adriana De Blois, Hub Dullens, Peter Steerenberg, Daan Crommelin]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Summary: Antigens presented on cell membranes or on liposomes are usually more immunogenic than antigens in soluble form, this being one of the reasons for the weak immunogenicity of extracted tumour-associated transplantation antigens (TATA). The main objective of this study is to solubilize TATA from tumour cells and to present them on a membrane-like structure to the immune system. Crude tumour cell membranes of SL2 lymphosarcoma cells (a spontaneously arising, weakly immunogenic tumour) were solubilized with octylglucoside or sodium deoxycholate, and reconstituted membranes (proteoliposomes) were prepared by detergent removal. Mice immunized s.c. with reconstituted membranes were protected against an i. p. challenge with tumour cells. Although octylglucoside solubilized only 41% of the membrane proteins, the reconstituted membranes were as immunoprotective as crude membranes. (Glyco)proteins were probably the major membrane components in the reconstituted membranes that induce immunoprotection, as mice immunized with preparations constituted of (glyco)lipids from SL2 cells could not reject SL2 cells. If Freund's complete adjuvant was used with the first immunization injection, no potentiation of the elicited immune responses was observed. Besides the membrane TATA, SL2 cells contained an apparently non-membrane-bound TATA, which was found in the cytoplasm. It is concluded that detergent solubilization of membranes and subsequent preparation of reconstituted membranes can be used to obtain membrane tumour-associated antigens that retain activity for induction of protective tumour immunity. The major advantage of this method is that membrane proteins are solubilized and are subsequently presented on a membrane-like structure that resembles the tumour cell membrane. On theoretical and practical grounds it provides a promising alternative for whole-cell vaccines.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1992</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Tumour vaccine</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Liposomes</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Reconstituted membranes</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Lymphoma cells</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bergers</subfield>
   <subfield code="D">Joep</subfield>
   <subfield code="u">Department of Pharmaceutics, Faculty of Pharmacy, University of Utrecht, P. O. Box 80.082, 3508 TB, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Den Otter</subfield>
   <subfield code="D">Willem</subfield>
   <subfield code="u">Department of Pathology, University Hospital Utrecht, P. O. Box 85.500, 3508 GA, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">De Groot</subfield>
   <subfield code="D">Jan</subfield>
   <subfield code="u">Department of Pathology, University Hospital Utrecht, P. O. Box 85.500, 3508 GA, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">De Blois</subfield>
   <subfield code="D">Adriana</subfield>
   <subfield code="u">Department of Pharmaceutics, Faculty of Pharmacy, University of Utrecht, P. O. Box 80.082, 3508 TB, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Dullens</subfield>
   <subfield code="D">Hub</subfield>
   <subfield code="u">Department of Pathology, University Hospital Utrecht, P. O. Box 85.500, 3508 GA, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Steerenberg</subfield>
   <subfield code="D">Peter</subfield>
   <subfield code="u">Laboratory for Pathology, National Institute of Public Health and Environmental Protection, P. O. Box 1, 3720 BA, Bilthoven, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Crommelin</subfield>
   <subfield code="D">Daan</subfield>
   <subfield code="u">Department of Pharmaceutics, Faculty of Pharmacy, University of Utrecht, P. O. Box 80.082, 3508 TB, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Cancer Immunology, Immunotherapy</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">34/4(1992-07-01), 233-240</subfield>
   <subfield code="x">0340-7004</subfield>
   <subfield code="q">34:4&lt;233</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">34</subfield>
   <subfield code="o">262</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF01741791</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF01741791</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bergers</subfield>
   <subfield code="D">Joep</subfield>
   <subfield code="u">Department of Pharmaceutics, Faculty of Pharmacy, University of Utrecht, P. O. Box 80.082, 3508 TB, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Den Otter</subfield>
   <subfield code="D">Willem</subfield>
   <subfield code="u">Department of Pathology, University Hospital Utrecht, P. O. Box 85.500, 3508 GA, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">De Groot</subfield>
   <subfield code="D">Jan</subfield>
   <subfield code="u">Department of Pathology, University Hospital Utrecht, P. O. Box 85.500, 3508 GA, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">De Blois</subfield>
   <subfield code="D">Adriana</subfield>
   <subfield code="u">Department of Pharmaceutics, Faculty of Pharmacy, University of Utrecht, P. O. Box 80.082, 3508 TB, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Dullens</subfield>
   <subfield code="D">Hub</subfield>
   <subfield code="u">Department of Pathology, University Hospital Utrecht, P. O. Box 85.500, 3508 GA, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Steerenberg</subfield>
   <subfield code="D">Peter</subfield>
   <subfield code="u">Laboratory for Pathology, National Institute of Public Health and Environmental Protection, P. O. Box 1, 3720 BA, Bilthoven, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Crommelin</subfield>
   <subfield code="D">Daan</subfield>
   <subfield code="u">Department of Pharmaceutics, Faculty of Pharmacy, University of Utrecht, P. O. Box 80.082, 3508 TB, Utrecht, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Cancer Immunology, Immunotherapy</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">34/4(1992-07-01), 233-240</subfield>
   <subfield code="x">0340-7004</subfield>
   <subfield code="q">34:4&lt;233</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">34</subfield>
   <subfield code="o">262</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
